HealthcareServices

Immunogenomics Industry Growth Insights: Revenue Forecast to 2030

February 25, 2026February 26, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the immunogenomics market from 2026–2035 with trusted insights from The Business Research Company

What level of CAGR-driven expansion is anticipated in the Immunogenomics Market between 2026 and 2030?

The immunogenomics market size has experienced rapid expansion in recent years. This market is projected to expand from $6.09 billion in 2025 to reach $7.07 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 16.1%. Historically, this growth has been fueled by several factors, including advancements in genomic sequencing technologies, an increasing comprehension of immune-related genetic variations, the broadening scope of oncology and infectious disease research, a rise in research funding, and the accessibility of high-throughput genomic tools.

The immunogenomics market size is projected to experience substantial expansion in the coming years. This market is anticipated to reach $12.73 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 15.8%. This projected growth throughout the forecast period stems from several factors, including the escalating demand for precision medicine solutions, the advancement of personalized vaccines and immunotherapies, the broadening of translational immunogenomics research, the increasing incorporation of multi-omics data, and a higher uptake of cloud-based genomic analytics. Key trends expected during this period encompass the growing adoption of next-generation sequencing for immune profiling, an increased application of bioinformatics tools in immune data analysis, an amplified emphasis on personalized immunotherapies, the expansion of genomic databases pertinent to immune research, and a greater integration of AI within immunogenomic studies.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28247&type=smp

What Drivers Are Affecting Demand-Supply Dynamics In The Immunogenomics Market?

The anticipated expansion of the immunogenomics market is linked to the growing incidence of infectious diseases. These conditions are caused by detrimental microorganisms, such as bacteria, viruses, fungi, or parasites, which can spread directly or indirectly between individuals. The rising occurrence of infectious diseases is attributed to increased global travel, which enables the swift transmission of pathogens across borders. Immunogenomics significantly improves the management of infectious diseases by allowing for precise examination of host immune responses and genetic susceptibility. It minimizes exploratory treatment approaches by pinpointing patient-specific immune determinants, thereby advancing diagnostic methods, vaccine creation, and tailored therapeutic plans. For instance, in February 2024, the UK Health Security Agency, a UK-based government agency, reported that tuberculosis cases in England, a contagious bacterial infection primarily affecting the lungs, climbed to 4,850 in 2023, marking an increase of 10.7% from 4,380 cases in 2022. Consequently, the escalating occurrence of infectious diseases is a primary catalyst for the growth of the immunogenomics market.

How Is The Immunogenomics Market Organized Into Various Segments?

The immunogenomics market covered in this report is segmented –

1) By Product Type: Instruments, Consumables, Software, Services

2) By Technology: Next-Generation Sequencing, Microarray, Polymerase Chain Reaction, Other Technologies

3) By Application: Oncology, Infectious Diseases, Autoimmune Disorders, Transplantation, Other Applications

4) By End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:

1) By Instruments: Sequencers, Microarray scanners, Flow cytometers

2) By Consumables: Reagents, Kits, Assay panels

3) By Software: Data analysis software, Bioinformatics tools, Visualization platforms

4) By Services: Sequencing services, Genomic profiling, Bioinformatics support

Which Trends Are Expected To Influence The Immunogenomics Market In The Upcoming Years?

Major companies operating in the immunogenomics market are concentrating on developing advanced solutions, such as a vaccine target prediction system, which facilitates automated end-to-end vaccine design and optimizes vaccine constructs by ensuring an optimal antigen sequence. This vaccine target prediction system operates as a computational platform, utilizing bioinformatics algorithms alongside genomic and immunomic data to pinpoint putative antigen molecules from pathogens or cancer cells. It then analyzes their structural properties to prioritize and select the most effective vaccine candidates with the highest potential to evoke protective immune responses. For instance, in September 2024, Evaxion Biotech A/S, a Denmark-based biotechnology company specializing in artificial intelligence-driven immunotherapy and vaccine development, launched its clinically validated AI-Immunology platform. This platform is an upgraded EDEN artificial intelligence prediction model, now including a novel toxin antigen predictor that enhances the accuracy and reliability of bacterial toxin antigen identification for next-generation bacterial vaccine development. Additionally, the platform simulates the immune system to create personalized and future-generation immunotherapies, having demonstrated strong correlations between its artificial intelligence-generated predictions and clinical outcomes.

Who Are The Top-Performing Companies In The Immunogenomics Market In Recent Years?

Major companies operating in the immunogenomics market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Illumina Inc., BGI Group, GenScript Biotech Corporation, CareDx Inc., Oxford Nanopore Technologies plc, Genewiz LLC, Adaptive Biotechnologies Corporation, GenomOncology LLC, Personalis Inc., Variantyx Inc., CD Genomics Inc., Sengenics Corporation, GeneCentric Therapeutics Inc., Immunogenomics Inc., ImmuQuad Biotechnologies Inc., Neomics Pharmaceuticals LLC, Yemaachi Biotech Ltd., BioAnalytica Biotechnology Systems Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/immunogenomics-global-market-report

How Does The Immunogenomics Market Perform Across Major Global Regions?

North America was the largest region in the immunogenomics market in 2025. The regions covered in the immunogenomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Immunogenomics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28247&type=smp

Browse Through More Reports Similar to the Global Immunogenomics Market 2026, By The Business Research Company

Immunomodulator Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunomodulator-global-market-report

Immunoassay Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report

Automated Immunoassay Analyzers Market Report 2026

https://www.thebusinessresearchcompany.com/report/automated-immunoassay-analyzers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795